May 17th each year marks "World Hypertension Day" (WHD), an international health awareness day initiated by the World Hypertension League (WHL) and supported by the World Health Organization (WHO). Its aim is to enhance public awareness of hypertension, a prevalent yet often overlooked health issue, and to promote effective prevention, early detection, and appropriate management of hypertension globally. The theme for 2024 is "Measure your blood pressure accurately, control it, and live longer!"
Hypertension, also known as high blood pressure, refers to a pathological condition where the force exerted by blood against the arterial walls remains persistently above normal levels, specifically with systolic pressure ≥140 mmHg and/or diastolic pressure ≥90 mmHg. Dubbed the "silent killer," hypertension may exhibit no overt symptoms in its early stages but can progressively damage vital organs such as the heart, blood vessels, brain, and kidneys, increasing the risk of severe health issues like cardiovascular diseases, stroke, and renal failure.
Hypertension is a leading cause of premature death worldwide, with approximately 1.28 billion people globally living with the condition, and alarmingly, at least 46% of adult hypertensive patients are unaware of their diagnosis, according to WHO data [1].
While the exact mechanisms underlying hypertension's onset remain unclear, numerous risk factors are identified, including advancing age, genetic predisposition, obesity, unhealthy dietary habits, and lifestyle practices.
The primary treatment for hypertension begins with lifestyle adjustments, with medication interventions, such as calcium channel blockers (CCBs), angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), diuretics, and β-blockers, introduced when lifestyle changes fail to adequately manage blood pressure.
Current research focuses on more precise regulation of the renin-angiotensin-aldosterone system (RAAS), including AGT inhibitors, aldosterone synthase inhibitors (ASI), novel mineralocorticoid receptor antagonists (MRA), endothelin receptor antagonists (ETRI), among others. These efforts aim to leverage new targets and mechanisms of action for effective hypertension management, particularly in resistant cases. Moreover, RNA interference techniques like AGT-siRNA offer a revolutionary approach to suppress RAAS at its source, potentially transforming hypertension therapy.
CUSABIO consistently dedicates itself to providing high-quality research reagents such as proteins, antibodies, and ELISA kits to researchers. Given the criticality and urgency of hypertension research, we have specially curated a list of more than 20 popular targets and related reagent products pertinent to hypertension studies below for your selection.
Product Name | Code | Target | Detection Range | Sensitivity |
---|---|---|---|---|
Rat Angiotensin converting enzyme,ACE ELISA Kit | CSB-E04490r | ACE | 31.25 ng/ml - 2000 ng/ml | 7.81 ng/ml |
Mouse Angiotensin converting enzyme,ACE ELISA Kit | CSB-E04492m | ACE | 1.56 ng/mL-100 ng/mL | 0.39 ng/mL |
Human Angiotensin Ⅰ Converting Enzyme,ACEⅠ ELISA Kit | CSB-E11269h | ACE | 18.75 pg/mL-1200 pg/mL | 4.7 pg/mL |
Rat Angiotensin converting enzyme 2, ACE2 ELISA Kit | CSB-E14308r | ACE2 | 0.02 ng/ml - 20 ng/ml | 0.02 ng/ml |
Human Angiotensin converting enzyme 2, ACE2 ELISA Kit | CSB-E04489h | ACE2 | 0.156 ng/mL-10 ng/mL | 0.039 ng/mL |
Mouse Angiotensin converting enzyme 2(ACE2)ELISA Kit | CSB-E17204m | ACE2 | 6.25 pg/mL-400 pg/mL | 1.56 pg/mL |
Bovine adiponectin,ADP ELISA Kit | CSB-E14054B | ADIPOQ | 3.125 μg/mL-50 μg/mL | 3.125 μg/mL |
Hamster adiponectin, C1Q and collagen domain containing (ADIPOQ)ELISA kit | CSB-EL001366HA | ADIPOQ | 0.469 ng/mL-30 ng/mL | 0.117 ng/mL |
Sheep adiponectin (ADIPOQ)ELISA kit | CSB-EL001366SH | ADIPOQ | 6.25 ng/mL-100 ng/mL | 3.125 ng/mL |
Human angiotensinogen (aGT) ELISA Kit | CSB-E08564h | AGT | 78 pg/mL-5000 pg/mL | 19.5 pg/mL |
Rat angiotensinogen (aGT) ELISA Kit | CSB-E08565r | AGT | 31.25 pg/mL-2000 pg/mL | 7.81 pg/mL |
Mouse angiotensinogen (aGT) ELISA Kit | CSB-E08566m | AGT | 3.12 ng/mL-200 ng/mL | 0.78 ng/mL |
Human RAC-alpha serine/threonine-protein kinase(AKT1) ELISA kit | CSB-EL001553HU | AKT1 | 0.312 ng/mL-20 ng/mL | 0.078 ng/mL |
Bovine Albumin(Alb) ELISA kit | CSB-E08664b | ALB | 0.313 μg/mL-80 μg/mL | 0.148 μg/mL |
Mouse Albumin (Alb)ELISA Kit | CSB-E13878m | ALB | 0.781 μg/mL-200 μg/mL | 0.110 μg/mL |
Dog Albumin(Alb) ELISA Kit | CSB-E15757c | ALB | 0.273 μg/mL-35 μg/mL | 0.266 μg/mL |
Sheep Albumin (Alb)ELISA Kit | CSB-E15839Sh | ALB | 350 μg/mL-21.88 μg/mL | 5.5 μg/mL |
Horse Albumin(Alb) ELISA Kit | CSB-E16205Hs | ALB | 1.25 μg/mL-80 μg/mL | 1.247 μg/mL |
Pig Albumin (Alb) ELISA Kit | CSB-E16207p | ALB | 0.03 μg/mL-7000 μg/mL | 0.03 μg/mL |
Goat Albumin (Alb)ELISA Kit | CSB-E15758G | ALB | 0.17 μg/mL-350 μg/mL | 0.17 μg/mL |
Product Name | Code | Target | Source | Tag Info |
---|---|---|---|---|
Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial (Active) | CSB-AP005671HU | ACE2 | Mammalian cell | C-terminal 6xHis-tagged |
Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial, Biotinylated (Active) | CSB-MP866317HU-B | ACE2 | Mammalian cell | C-terminal mFc-Avi-tagged |
Recombinant Human Angiotensin-converting enzyme 2 (ACE2), partial (Active) | CSB-MP866317HU | ACE2 | Mammalian cell | C-terminal hFc-tagged |
Recombinant Macaca fascicularis Angiotensin-converting enzyme (ACE2), partial (Active) | CSB-MP3414MOV | ACE2 | Mammalian cell | C-terminal hFc-tagged |
Recombinant Paguma larvata Angiotensin-converting enzyme 2 (ACE2), partial (Active) | CSB-MP684964PAL | ACE2 | Mammalian cell | C-terminal hFc-tagged |
Recombinant Mesocricetus auratus Angiotensin-converting enzyme (Ace2), partial | CSB-EP4885MRG | Ace2 | E.coli | N-terminal 10xHis-tagged and C-terminal Strep II-tagged |
Recombinant Bovine Adiponectin (ADIPOQ) | CSB-EP661101BO | ADIPOQ | E.coli | N-terminal 6xHis-SUMO-tagged |
Recombinant Mouse Adiponectin (Adipoq) | CSB-EP723362MO | Adipoq | E.coli | N-terminal 6xHis-tagged |
Recombinant Mouse Adiponectin (Adipoq), partial | CSB-RP079474m | Adipoq | E.coli | N-terminal 6xHis-tagged |
Recombinant Bovine Adiponectin (ADIPOQ) | CSB-YP661101BO | ADIPOQ | Yeast | N-terminal 6xHis-tagged |
Recombinant Horse Adiponectin D (ADIPOQ), partial | CSB-EP4093HO | ADIPOQ | E.coli | Tag-Free |
Recombinant Human Angiotensinogen (AGT), partial | CSB-EP001463HU1 | AGT | E.coli | N-terminal 6xHis-SUMO-tagged |
Recombinant Enterobacteria phage T4 DNA alpha-glucosyltransferase (agt) | CSB-EP356278EDZ | agt | E.coli | N-terminal 10xHis-SUMO-tagged and C-terminal Myc-tagged |
Recombinant Human RAC-alpha serine/threonine-protein kinase (AKT1) | CSB-EP001553HU | AKT1 | E.coli | N-terminal GST-tagged |
Recombinant Rat RAC-alpha serine/threonine-protein kinase (Akt1) | CSB-EP001553RA | Akt1 | E.coli | N-terminal 10xHis-tagged |
Recombinant Mouse Serum albumin (Alb) | CSB-BP001561MO | Alb | Baculovirus | C-terminal 9xHis-tagged |
Recombinant Dog Serum albumin (ALB) | CSB-EP001561DO | ALB | E.coli | N-terminal 6xHis-tagged |
Recombinant Macaca fascicularis albumin (ALB) | CSB-EP001561MOV | ALB | E.coli | N-terminal 6xHis-SUMO-tagged |
Recombinant Macaca fascicularis albumin (ALB) | CSB-MP001561MOV | ALB | Mammalian cell | N-terminal 6xHis-Myc-tagged |
Recombinant Dog Serum albumin (ALB) | CSB-YP001561DO | ALB | Yeast | N-terminal 6xHis-tagged |
Product Name | Code | Target | Species Reactivity | Tested Applications |
---|---|---|---|---|
ACE Recombinant Monoclonal Antibody | CSB-RA268157A0HU | ACE | Human | ELISA, IHC |
AGT Recombinant Monoclonal Antibody | CSB-RA263831A0HU | AGT | Human | ELISA, IHC |
Phospho-AKT1 (T450) Recombinant Monoclonal Antibody | CSB-RA001553A450phHU | AKT1 | Human | ELISA, WB |
Phospho-AKT1 (Ser473) Recombinant Monoclonal Antibody | CSB-RA001553A473phHU | AKT1 | Human | ELISA, WB, IHC, IF, IP |
AKT1 Recombinant Monoclonal Antibody | CSB-RA917625A0HU | AKT1 | Human, Mouse, Rat | ELISA, WB, IHC, IF |
ALB Recombinant Monoclonal Antibody | CSB-RA264109A0HU | ALB | Human | ELISA, FC |
CD4 Recombinant Monoclonal Antibody | CSB-RA004935A0HU | CD4 | Human | ELISA, WB, IHC |
CRP Recombinant Monoclonal Antibody | CSB-RA988767A0HU | CRP | Human | ELISA, IHC |
Phospho-EGFR (Y1092) Recombinant Monoclonal Antibody | CSB-RA007479A1092phHU | EGFR | Human | ELISA, WB |
Phospho-EGFR (Y1068) Recombinant Monoclonal Antibody | CSB-RA007479A1068phHU | EGFR | Human | ELISA, WB |
EGFR Recombinant Monoclonal Antibody | CSB-RA159341A0HU | EGFR | Human | ELISA, WB, IHC, IF, FC |
EGFR Recombinant Monoclonal Antibody | CSB-RA794061A0HU | EGFR | Human | ELISA, WB, IHC |
EGFR Recombinant Monoclonal Antibody | CSB-RA159341MA1HU | EGFR | Human | ELISA, IHC, FC |
IL6 Recombinant Monoclonal Antibody | CSB-RA011664MA1HU | IL6 | Human | ELISA |
INS Recombinant Monoclonal Antibody | CSB-RA584163A0HU | INS | Human | ELISA, IHC |
Product Name | Code | Target | Species Reactivity | Tested Applications |
---|---|---|---|---|
ACE Monoclonal Antibody | CSB-MA904961 | ACE | Human,Mouse,Rat | ELISA, WB |
ADIPOQ Monoclonal Antibody | CSB-MA079461A0m | ADIPOQ | Human | ELISA |
AKT1 Monoclonal Antibody | CSB-MA011037 | AKT1 | Human,Mouse,Pig,Rat | ELISA, WB |
ALB Monoclonal Antibody | CSB-MA076752 | ALB | Human | ELISA, WB, IHC |
CD4 Monoclonal Antibody | CSB-MA000228 | CD4 | Human,Mouse,Rat | ELISA, IHC |
CD4 Monoclonal Antibody,Purified | CSB-MA783233 | CD4 | Human | ELISA, FC |
CRP Monoclonal Antibody | CSB-MA027411E0m | CRP | Human | ELISA, IHC |
EGFR Monoclonal Antibody | CSB-MA000199 | EGFR | Human | ELISA, WB, IHC, IF |
EGFR Monoclonal Antibody | CSB-MA000293 | EGFR | Human | ELISA, WB |
IL6 Monoclonal Antibody | CSB-MA067571A0m | IL6 | Human | ELISA, WB, IHC |
NOS3 Monoclonal Antibody | CSB-MA000326 | NOS3 | Human,Mouse,Rat | ELISA, WB |
NPPB Monoclonal Antibody | CSB-MA168601A0m | NPPB | Human | ELISA, IHC |
TNF Monoclonal Antibody | CSB-MA084771A0m | TNF | Bovine | ELISA |
TNF Monoclonal Antibody | CSB-MA080271 | TNF | Human,Mouse,Rat | ELISA, WB, IHC |
TNF Monoclonal Antibody | CSB-MA080272 | TNF | Human,Mouse,Rat | ELISA, WB, IHC |
Product Name | Code | Target | Species Reactivity | Tested Applications |
---|---|---|---|---|
Ace Antibody | CSB-PA001149LA01RA | Ace | Rat | ELISA, IHC |
ACE Antibody | CSB-PA007661 | ACE | Human, Mouse, Rat | ELISA, WB, IHC |
ACE Antibody | CSB-PA794185 | ACE | Human, Mouse | ELISA, IHC |
ACE Antibody | CSB-PA152113 | ACE | Human, Mouse, Rat | ELISA, WB |
ACE Antibody | CSB-PA172536 | ACE | Human, Mouse, Rat | ELISA, WB |
ACE Antibody | CSB-PA271234 | ACE | Human, Mouse, Rat | ELISA, WB, IHC |
ACE Antibody | CSB-PA575032 | ACE | Human, Mouse, Rat | ELISA, WB, IHC |
ACE2 Antibody | CSB-PA866317LA01HU | ACE2 | Human | ELISA, IHC, IF |
Ace2 Antibody | CSB-PA688690OA01RA | Ace2 | Rat | ELISA, WB |
ACE2 Antibody | CSB-PA040178 | ACE2 | Human, Mouse | ELISA, WB |
ACE2 Antibody | CSB-PA001150GA01HU | ACE2 | Human, Mouse, Rat | ELISA, WB |
ACE2 Antibody | CSB-PA111496 | ACE2 | Human | ELISA, IHC |
ACE2 Antibody | CSB-PA025395 | ACE2 | Human, Mouse, Rat | ELISA, IHC |
ACE2 Antibody | CSB-PA445794 | ACE2 | Human, Mouse, Rat | ELISA, IHC |
Adipoq Antibody | CSB-PA07946A0Rb | Adipoq | Mouse | ELISA |
ADIPOQ Antibody | CSB-PA07956A0Rb | ADIPOQ | Human, Mouse | ELISA, WB, IHC |
ADIPOQ Antibody | CSB-PA07957A0Rb | ADIPOQ | Human | ELISA, IHC |
ADIPOQ Antibody | CSB-PA618019YA01HU | ADIPOQ | Human, Mouse | ELISA, WB, IHC |
ADIPOQ Antibody | CSB-PA661101LA01BO | ADIPOQ | Bovine | ELISA |
ADIPOQ Antibody | CSB-PA661101YA01BO | ADIPOQ | Bovine | ELISA, WB |
References
[1] https://www.who.int/news-room/fact-sheets/detail/hypertension